Wedbush adds Wave Life Sciences to Best Ideas List, ups target to $33

Wedbush added Outperform-rated Wave Life Sciences (WVE) to the firm’s Best Ideas List and raised the price target on the stock to $33 from $20 and keeps an Outperform rating on the shares. The firm believes this is “just the beginning of the next wave.”